Navigation Links
Pfizer and Bristol-Myers Squibb Finalize Agreement for Worldwide Collaboration on Metabolic Disorders Program
Date:8/27/2007

- Companies Will Jointly Conduct Phase III Development and

Commercialization of DGAT-1 Inhibitor Compounds -

NEW YORK, and PRINCETON, N.J., Aug. 27 /PRNewswire-FirstCall/ -- Pfizer Inc. (NYSE: PFE) and Bristol-Myers Squibb Company (NYSE: BMY) ("companies") today announced that they have finalized a definitive agreement for the worldwide collaboration to research, develop and commercialize DGAT-1 inhibitors, a collaboration first announced on April 26, 2007. Pfizer's DGAT- 1 discovery program includes advanced pre-clinical compounds with potential applications for the treatment of metabolic disorders, including obesity and diabetes. The program also includes DGAT-1 inhibitors in-licensed by Pfizer from Bayer Pharmaceuticals Corporation in June 2006, including a pre-clinical compound (known as PF-04415060 or BAY 74-4113) originally discovered by Bayer.

Under terms of the agreement, Pfizer will be responsible for all research and early-stage development activities for the metabolic disorders program, and the companies will jointly conduct Phase III development and commercialization activities.

"The worldwide incidence of metabolic disorders is increasing rapidly, and complications from diabetes and obesity are leading causes of disability and mortality globally. DGAT-1 inhibitors have shown promise in pre-clinical testing, and this research program has potential to yield several compounds that may improve treatment options for patients," said
'/>"/>

SOURCE Bristol-Myers Squibb
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related biology technology :

1. Mirus Bio, Pfizer enter multimillion-dollar research agreement
2. Pfizer-Pharmacia Fallout Gives Celltech A CEO
3. Sale of Norlight Telecommunications is finalized
4. WARF enters licensing agreements for stem cell products
5. Quick peeks, Clawback Agreements, and the rules of electronic discovery
6. Virent enters agreement with Shell Oil unit to make hydrogen with biomass
7. WARF expands license agreement with Advanced Cell Technology
8. Lucigen Corp. enters global licensing agreement
9. GE Healthcare enters agreement with Canadian health authority
10. New angel capital centered on GenTel agreement with big pharma
11. Prodesse enters patent agreement with Roche
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/13/2008)... Toronto Stock Exchange Symb... BioMS Medical Corp (TSX: MS),a leading developer...y,announced that Dr. Mark Krantz, Vice President S...the TIDES(R) - Oligonucleotide and Peptide,Technol...s., WHEN: Tuesday May 20th at 10:45 am (PDT...
(Date:5/13/2008)... Gift is among largest in the Coll...- The Albert Einstein College of,Medicine of Yeshi... a major,gift of $25 million -- one of the largest...and David S. Gottesman. A photo of the Gottesmans ...i-bin/prnh/20080513/NYTU059-a ), (Logo: http://w...
(Date:5/13/2008)... WEINHEIM, Germany, May 13 /- Ca...e delicacies. However in view of the over fished,s...an only be satisfied,with sustainable aquaculture....of experience and a significant advantage in know-...ed a turnkey aquaculture plant to an operator,in G...
(Date:5/13/2008)... QUEBEC CITY, May 13 /... a global biopharmaceutical company focused on,end...the article titled,"Placebo-controlled dose-rangin...H antagonist cetrorelix in patients with symptomat...cepted for publication in an,upcoming issue of the...
Breaking Biology Technology:BioMs Medical to present at TIDES(R) Conference 2Albert Einstein College of Medicine Receives $25-Million Gift to Support Stem Cell and Epigenomic Research and Clinical Skills Training 2Albert Einstein College of Medicine Receives $25-Million Gift to Support Stem Cell and Epigenomic Research and Clinical Skills Training 3Albert Einstein College of Medicine Receives $25-Million Gift to Support Stem Cell and Epigenomic Research and Clinical Skills Training 4Albert Einstein College of Medicine Receives $25-Million Gift to Support Stem Cell and Epigenomic Research and Clinical Skills Training 5Sturgeon and Caviar From Aquaculture: United Food Technologies AG Hands Over Turnkey Plant 2AEterna Zentaris: Article on Phase 2 Trial with Cetrorelix in BPH to be Published in European Urology Journal 2AEterna Zentaris: Article on Phase 2 Trial with Cetrorelix in BPH to be Published in European Urology Journal 3AEterna Zentaris: Article on Phase 2 Trial with Cetrorelix in BPH to be Published in European Urology Journal 4AEterna Zentaris: Article on Phase 2 Trial with Cetrorelix in BPH to be Published in European Urology Journal 5AEterna Zentaris: Article on Phase 2 Trial with Cetrorelix in BPH to be Published in European Urology Journal 6
...le today announced his "Grow Wisconsin" initiative...ecommendations is to increase broadband and commun...,Mike Tye, AT&T regional vice present of Law and G...ed by the "Grow Wisconsin" initiative unveiled tod...ted to enhancing and expanding its competitive tel...
... gathered over 100 executives and leaders of Wisco...sday night to preview his new economic growth pack...the Wisconsin Biotechnology Association leadership...otechnology CEO,s and leading UW-Madison researche... from governor was his perception about the world ...
...ents Compensation Fund could be illegal , ,While ...e expressed support yesterday for Gov. Jim Doyles ...kfield Republican expressed support, but takes is...re capital authority. , ,Kanavas reserved his stro...rom the Patients Compensation Fund a cache of dol...
...night. Your 4 year old has stomach pains, and you ...ide all sorts of personal medical information incl...urance information. Meanwhile your child is in pai...at the front desk everything. Then you wait; maybe...leeding or an apparent emergency. Next you meet a ...
Other Biology Technology:Governor Gathers Biotech Leaders at his Residence 2Republicans criticize Doyles growth package 2Republicans criticize Doyles growth package 3Republicans criticize Doyles growth package 4Childrens Medical Hospital of Wisconsin Goes Digital 2Childrens Medical Hospital of Wisconsin Goes Digital 3Childrens Medical Hospital of Wisconsin Goes Digital 4
(Date:5/12/2008)...ijuana (MJ) include risk for heart attacks and str...The active chemical in MJ called delta-9-tetrahyrd...ts by binding to cannabinoid (CB) receptors locate...ists have found CB receptors in many organs includ...In this study, researchers investigated if persist...
(Date:5/12/2008)...mystifying the role protein clumps play in the dev... have created a stunning three-dimensional picture... microscopy. The study, in this weeks issue of the...reports that researchers from Brandeis University ...a, Germany, have shownfor the first timehow A-beta...
(Date:5/12/2008)...ttract more females and as a result are most succe...ng point of many studies looking for factors that ...t reasonable to assume that birds see what we see?...can Naturalist, Uppsala researchers show that our ...e results mean that many studies on sexual selecti...
(Date:5/12/2008)...eing launched at the John Innes Centre in Norwich ..., This knowledge can be used to improve the abili...ow more sustainably with reduced nitrogen fertilis...the Biotechnology and Biological Sciences Research...xpertise in TILLING, a technique to detect mutant ...
Breaking Biology News(10 mins):Seeing Alzheimer's amyloids 2Human vision inadequate for research on bird vision 2Chronic Illness Often a Taboo Subject 3A Survey 3475 1Chronic Illness Often a Taboo Subject 3A Survey 3475 2Chronic Illness Often a Taboo Subject 3A Survey 3475 3Anticlotting drug found to be safe in sickle cell patients 3472 1Anticlotting drug found to be safe in sickle cell patients 3472 2A tiny pinch from a z ring helps bacteria cells divide 760 1A tiny pinch from a z ring helps bacteria cells divide 760 2A tiny pinch from a z ring helps bacteria cells divide 760 3Obesity Boosts Esophageal Cancer Risk 3469 1Obesity Boosts Esophageal Cancer Risk 3469 2
...flexible. Thanks to this flexibility--the arm is s...rees of freedom"--the octopus is able to generate ...y the human arm. Nonetheless, despite the huge evo...n the octopus and vertebrates, the octopus arm act...he octopus performs precise point-to-point movemen...
...tors lead to neural tube defects in 1 in every 1,0...bortion. One cause of these defects is the failure... middle of the developing neural tube. , A stud...eport on the molecular mechanism that directs cell...oping neural tube of vertebrates. , Marek Mlod...
...ting antibiotic use in food-producing animals may ...eria found in its citizens, according to an articl...ses, now available online. , Campylobacter jejuni... in industrialized countries. Drug resistance can ...ians to treat, and can result in longer bouts of d...
...highly organized, with specialized areas for diffe...onents around. Researchers from the University of ...w offer the first imaging evidence from live cells...cell nucleus. , Genes that are active are located...e inactive genes are at the periphery. But scienti...
Other Biology News:How the octopus forms an elbow 2Less antibiotic use in food animals leads to less drug resistance in people, study shows 2Movement of chromosome in nucleus visualized 2Movement of chromosome in nucleus visualized 3
Rabbit polyclonal to Leucyl tRNA synthetase ( Abpromise for all tested applications). Antigen: L930-H1176 denatured human recombinant LRS. Entrez Gene ID: 3926 Swiss Protein ID: Q9P2J5
WNV Core Antibody
Mouse monoclonal [YPF19] to Yersinia pestis ( Abpromise for all tested applications).
PhosphoSafe Extraction Reagent extracts cytosolic proteins from mammalian and insect cells while preserving their phosphorylation state. The reagent, an enhancement of the CytoBuster Protein Extracti
Biology Products: